Rising Prevalence of Gastro-Intestinal Diseases Boosts Microbiome Therapeutics Industry

The microbiome therapeutics industry has garnered $314.4 million revenue in 2021, and it is projected to rise at the rate of 23.1% in the coming years, to capture the $2,036.4 million industry size.

The microbiome plays a substantial role in both types of illnesses gastrointestinal, and non-gastrointestinal, making it a lucrative target for new therapies. In addition, industry growth is ascribed to the potential of digestive-related therapeutics to mitigate the inadequacies in traditional treatment.

There is a higher possibility of such therapeutics to cater to the demand of present therapeutics choices, rise in the illness dimension, participation of academic institutions, rising strategic activities, and recognizing the businesses operating in the field.

Opportunities in the Industry

The presence of innovative players in a smaller number provides numerous opportunities to grow for major stakeholders and attain businesses that involve studying microbiomes for discovering new drugs and drug targets for multiple indications, such as liver disorders, obesity, metabolic disorders, and diabetes.

The key industry players are focusing on strategic alliances and collaborations to expand themselves through product pipelines with efficient R&D methods. In addition, numerous companies have participated in collaborations and partnerships in the last two years, to remain on the competitive edge.

Businesses reduce the selling price of goods and extend state-of-the-art healthcare access to a wider populace section, to propel the usage of digestive health-related therapies. It offers vendors alluring opportunities for growth.

The fecal microbial transplant captures a substantial share of the industry revenue, and it is projected to capture over 84% of the revenue share in 2030. It is owed to the rising fecal microbial transplant usage and the presence of FMT in the capsule form, that has increased the acceptability of the C. difficile infection treatment for patients.

Moreover, the microbiome drugs demand is expected to rise at a higher rate in the coming years. It is led by the rising research activities conducted by research institutes to discover the additional therapeutic FMT uses, a strong pipeline, and the development of advanced medications.

Microbiome therapeutics contribute to gastrointestinal and infectious disease treatment. It contributes more than 92% of the industry share. Moreover, a slew of such treatments focuses on gut-relevant disorders, such as inflammatory bowel disease, C. diff. infection (CDI), and ulcerative colitis, are in the developmental stage and offer massive economic potential in the coming years.

Get More Details Microbiome Therapeutics Market Share

Read More

Why Do We Need Medical Device Analytical Testing Outsourcing?

Several companies of medical devices outsource analytical testing tasks to reduce the costs, hasten the launch of novel products into the analytical testing outsourcing business, and eliminate commercial risks. 

IMDs, or implantable medical devices, are being used more often to improve patient outcomes in terms of health. The balance between complexity, power consumption, reliability, and cost must be struck by IMD designers.

The global demand for medical device analytical testing outsourcing is growing due to the government's increasingly stringent quality certificate regulations. Medical device manufacturers are engaging consultants to assist them in understanding the paperwork and legal requirements for pre-market approval.

The demand for medical device analytical testing outsourcing is predicted to hit $10,904.8 million by 2030. This is due to an increase in the number of small-scale producers of medical devices, increased demand for medical device efficacy and security verification and validation, and the implementation of stringent government regulations.

Increasing Number of Cardiovascular Diseases

Due to the rising frequency of heart problems, there is a high requirement for cardiovascular equipment, which is why outsourcing is expanding. It is estimated that more than 17 million people die each year from cardiovascular diseases. That figure will increase to 23.6 million by 2030.

Moreover, CVDs are quite complex, requiring the safest and most user-friendly diagnostic and therapeutic tools imaginable.

To expand production and outsource the analytical testing process, medical device companies are turning to contract development and manufacturing organizations, along with a growth in the number of patients.

Reprocessed Devices: Why Are They So Popular?

Cleaning up any visible debris, properly sanitizing the equipment, packaging and labeling it, and ultimately holding the reprocessor accountable for any unfavorable effects the item may have been all steps in the reprocessing process.

Even though medical device reprocessing is still relatively new globally, it has already been demonstrated to provide healthcare professionals with several significant benefits.

Orthopedic blades, fixation tools, endotracheal tubes, electrosurgical electrodes, electrophysiology catheters, and ophthalmic knives may all now be recycled in large quantities.

Why Do Hospitals Contract Out Testing for Analyses?

Hospitals' increasing need for medical devices built with emerging technology is a significant factor pushing the use of analytical testing for medical devices among hospitals. These facilities store cutting-edge medical technologies that require thorough analysis and testing to work at their best.

Hospitals are one of the most important target industries for contract development and manufacturing organizations since they are the principal consumers of refurbished medical equipment, which necessitates analytical services.

Get More Details Medical Device Analytical Testing Outsourcing Market Competitive Landscape

Read More

Why Will Large Hospitals Drive Hospital Risk Management Market?

The major drivers in the global hospital risk management market are the high prevalence of long-term diseases and the increasing count of medical errors. In 2021, the market was valued at $1,115.4 million, and it is projected to touch $3,482.3 million by 2030. The market will advance at a 13.5% CAGR from 2021 to 2030. Medical errors lead to approximately 3 million deaths every year in comparison to mortality from malaria, HIV, and tuberculosis. Furthermore, extensive governmental support, the increasing integration of information technology in hospitals and clinics, and swift modernization will drive the market.

Furthermore, the second-largest shareholder in the hospital risk management market is the workflow management category, accounting for about one-fifth of the total revenue, in 2021. There is huge pressure on the healthcare infrastructure because of the surging incidence of long-term illnesses. Around 70% of the global deaths are because of chronic diseases per year, accounting for approximately the death of 40 million people each year. Apart from offering better effectiveness in medical data control, the category improves internal operations via automation.

By 2030, the biggest share in the hospital risk management market will be held by the large hospital category, accounting for approximately 60% of the total market share. This can be ascribed to a swift integration of EHRs in the healthcare centers., surging hospital expenditure, and an increasing count of large hospitals. To remove the medical errors, there is a dire need for hospital risk management to enhance the operations of EHR systems. The highest hospital bed density is witnessed in Japan with approximately 13 beds for every 1000 people.

In 2021, the global hospital risk management market was led by North America. This is because of the surging adoption of data science to ease the workflow in healthcare centers, the paradigm shift of the on-premises risk management to cloud-based solutions, and the surging count of market players in the U.S. There is a high investment in the healthcare sector due to rising medical errors. Approximately $40 billion is spent on patients bothered with medication errors.

Hence, an increasing count of medical errors and a high prevalence of long-term diseases will provide lucrative opportunities to the market players to gain a competitive edge.

Get More Details Hospital Risk Management Market Growth Factors, Company Profile Analysis

Read More

Ocular Implants Market Trends, Drivers, and Growth Forecast to 2030

Our vision gradually declines as we age. Now and then, people need reading glasses or additional visual aids as their age increases, while others face the clouding of their natural lenses. Patients with weakened vision because of cataracts do not have to live with cloudy vision throughout their life. They can get a renewed sight in the form of an intraocular lens implant.

 This implant could lessen the need for corrective eyewear when the natural lens is substituted with an intraocular lens. So, can the intraocular lens be detached and substituted, what is the lasting duration of cataract lenses? If you have queries about IOLs, you can get some of your questions answered by reading this blog.

What is the Lasting Duration of cataract lenses?

Consequently, how long do cataract lenses last? Different from the eye's natural lenses, IOLs do not collapse and are never required to be replaced. To reap these lifelong aids, patients should follow any post-operative care instructions given by the doctor after the surgery. Full recovery can occur in 1 – 2 days, but this is  subject to on your original eyesight and primary health conditions. The doctors can schedule follow-up arrangements to ensure that the healing process is going as planned. 

You can always follow these recovery instructions after the laser cataract surgery:

• Get an adequate amount of rest and sleep

• Avoid rubbing or touching your eyes

• Take the prescribed medications as directed by the physician

• Wash your hands thoroughly before making use of any drops

With the increase in the number of people suffering from cataracts and various other kinds of problems related to the eyes, the demand for ocular implants is on the rise. It will reach a value of above $17,279 million by 2030.

Get More Details Ocular Implants Market Growth Factors, and Demand Forecast to 2030

Read More

Increasing Incidences of Organ Failure Leads to Rising Demand for Transplantation

Transplantation in healthcare helps in saving the lives of numerous people whose organs, or cells have stopped functioning. When no other alternative works, human cells, tissues, or organs are transplanted.

Transplantation can be defined as tissue, organ, or cell group removal from donor to recipient, or positioning from one site to another in the same person. In 2021, the transplantation industry contributes $13,605.9 million, and it is projected to advance at a rate of 9.2% and capture $30,117.5 million in 2030.

Transplantation is not a simple healthcare procedure in medicine. It involves numerous complications, as the transplantation of organs or tissues from one person to another, may cause rejection from the recipient’s immune system, which may destroy the donated organ or tissue, to prevent such immune response medication is required. Under such conditions, treatment may vary depending on the organ and tissue being transplanted, compatibility level between recipient and donor, and various other factors.

 Some of the major transplantation in healthcare

 

• Patients suffering from corneal blindness can get their eyesight back with corneal grafting
• Hematopoietic stem cell transplantation can help in curing congenital diseases along with leukemia.
• Recipient patients of human heart valve transplantation do not require to undergo long-term anti-coagulation therapy, done under the best replacement situation.
•  

Xenotransplantation: Living cells, organs, or tissues of animals or humans, along with cells, body fluids, tissues, or organs ex vivo with xenogeneic materials being alive, are capable of constituting an alternative to human origin material, and fulfill the requirement for human material for transplantation.

 Tissue Transplantation in the Same Person

The most prevalent transplantation is tissue transplantation, in which one tissue from one part of the body is transplanted to another part through autograft, the process is known as autotransplantation.

 Several types of autografts:

 Skin Graft: It involves the usage of healthy skin to support the healing of the wound or burn on another body part.

 Blood Vessel Graft: It helps in providing an alternative passage for blood flow to bypass a blocked artery, such as heart bypass surgery.

 Bone Graft: Bone grafting helps in reconstructing the damaged area of the body, such as in spinal fusion.

 Bone Marrow Graft: For instance, bone marrow needs to be collected in cancer patients before, they undergo chemotherapy. As, after high-dose of chemotherapy results in the replacement of blood stem cells.

The increasing incidences of chronic diseases, such as solid tumors, myelodysplastic disorders, plasma cell disorders, immune system disorders, and kidney failures, are leading to the growing prevalence of transplantation.

Increasing awareness of organ donations, technological advancements such as kidney transplantation with robot assistance, and rising success rates in organ transplantation, increase people’s confidence to undergo organ transplantation.

The rising elderly population increases the demand for orthobiologics for reducing pain, fast tissue healing, and restoration of normal functioning. Numerous, startup companies are receiving investments to expand their operations. For example, a shoulder replacement manufacturer, Catalyst OrthoScience raised $12.3 million in the financing round and utilized it to launch Archer 3D Targeting Imaging Software and Archer R1 Reverse Shoulder System.

Therefore, the rising elderly population increases the prevalence of transplantation, with growing incidences of organ failure, or chronic diseases.

 Read More Transplantation Market Scope and Size

Read More

Know Everything About Disposable Blood Bag: Importance of Disposable Blood Bag

Systems for collecting, storing, transporting, and transfusing human blood and products obtained from it are available as disposable biomedical goods called blood bag systems. Hospitals, blood banks, government initiatives, and NGOs all use disposable blood bags to store blood donations that have been received.

To reduce the importation of blood components from Western nations, government-funded programs in some Asian countries are concentrating on developing blood separation technology. The need for blood bags in Asia is also fueled by government programs that boost volunteer blood collection campaigns.

Global demand for disposable blood bags is anticipated to increase due to the growing frequency of blood-related illnesses and the increased need for blood transfer and collection bags. 

Additionally, it is anticipated that there will be an increase in the need for blood-derived products and transfusion treatments during the next several years.

Technological Advancement 

With the launch of new blood bags equipped with RFID tracking technologies, efficiency has grown, visibility has improved, and blood bags are now more securely protected while in transit. The position of blood bags may be tracked in real-time using a UHF Gen-2 RFID application provided by Alien Technology called UHF RFID-based-hemo-derivative blood bag tracking.

In blood banks, automated blood processing technology allows for more dependable and safe blood separation. Blood collecting facilities use cell separators to improve donor protection and blood component quality. For the separation of blood components, blood collection facilities are currently increasingly oriented toward automated portable devices.

Moreover, the requirement for whole blood and blood products, including RBC, plasma, hemoglobin, platelets, and WBC, is driven by the rise in surgical procedures, medical crises, chronic illnesses, and blood-related research. This will ultimately increase the demand for blood bags.

Browse Full Report Disposable Plastic Blood Bags Market Production, and Revenue

Read More

Understanding All about Schizophrenia - Mental Wellness

Schizophrenia is a mental disorder where a person has delusions, hallucinations and other mental difficulties. It interferes with the capability to think sensibly, control emotions, make pronouncements etc. It can comprise breaks with reality and disturb thought processes and everyday functioning of people. Schizophrenia is a mental illness where a person is incapable to differentiating between reality and imagination. It can happen at any age, majorly in the late teens to early 30s. About 1% of the people worldwide have schizophrenia.

What are the Causes?

Genetic Factors: People having a family history of schizophrenia are more prone to this this mental disorder. No single gene is accountable for this ailment; rather, a combination of several is related with an augmented risk of schizophrenia.

Environmental Factors: It is believed that trauma or viral infection or undernourishment throughout pregnancy surges the danger of schizophrenia. Other factors contributing to this disease are viral infections in early age and substance abuse during teenage.

Brain Abnormalities: Imbalance in the neurotransmitters like glutamate, dopamine, and serotonin may surge the risk of schizophrenia. Other brain abnormalities like, enlarged brain ventricles can also bring about schizophrenia as it disturbs the decision-making abilities of the brain.

What are the Symptoms?

Positive Symptoms: These are called psychotic symptoms and denote behaviors not related with healthy persons. They are disturbances added to the being’s personality. The harshness of these symptoms varies with time. 

Negative Symptoms: They are allied with disturbances to the normal feelings and actions of a person. These are capabilities not present in an individual. 

Cognitive Symptoms: These are mental and behavioral problems problematic to detect and treat. There are disorganized symptoms like confusion, thought disorder, and disorientation, trouble expressing feelings and memory problems.

Characteristic Symptoms 

Delusions: These are false opinions clanged on by a person. For instance, imagining conspiracies deprived of any evidence, trusting that the person is special or famous, or conception of a major illness without any grounds.

Hallucinations: These comprise smelling, seeing, or feeling things that are not there, or hearing voices unheard by others

Disorganized Speech: These denote to recurrent incoherence while speaking.

Diagnosis of Schizophrenia 

Physical Exam: a thorough physical examination will be conducted to find the medical problems accountable for this disorder.

Medical History: The family and personal health history of an individual is studied in detail.

Psychiatric Evaluation: The behavior of an individual is observed for any mood swings, hallucinations, delusions etc.

Lab Tests: Urine and blood tests, MRI and CT scan can be conducted for ruling out the possibilities of further health complications.

Treatment for Schizophrenia

Medication: Some neuroleptic medications like Quetiapine Aripiprazole, can decrease the harshness of schizophrenia. But medicines have some side effects like dizziness, weight gain, sleepiness etc. Sometimes, antidepressants can be prescribed for controlling the symptoms.

Psychosocial Treatments: These consist of counselling programs, therapy sessions and social skills training for improving the coping skills, improve communication and stress management.

Self-Help: A person can also do certain things by oneself for managing the symptoms and improving the way one feels and increase the self-esteem. For instance, looking for social support, guaranteeing passable sleep, remaining fit, evading alcohol abuse, keeping oneself involved in activities.

With people increasingly succumbing not only to Schizophrenia, nut other mental health diseases as well, the demand for treatments is on the roll and the value will reach $226 billion by 2030.

Get More details Mental Wellness Market Size, Share, Revenue, and Strategic Insights

Read More